Atrys Health Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Isabel Lozano Fernandez
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.4% |
| Management average tenure | no data |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Why Investors Shouldn't Be Surprised By Atrys Health, S.A.'s (BME:ATRY) P/S
Dec 25
Atrys Health, S.A.'s (BME:ATRY) 38% Share Price Surge Not Quite Adding Up
May 25Is Atrys Health, S.A. (BME:ATRY) Trading At A 44% Discount?
Sep 09The Returns At Atrys Health (BME:ATRY) Aren't Growing
Jun 27Returns On Capital Are Showing Encouraging Signs At Atrys Health (BME:ATRY)
Nov 26Atrys Health (BME:ATRY) Might Have The Makings Of A Multi-Bagger
Aug 12Did You Miss Atrys Health's (BME:ATRY) Whopping 387% Share Price Gain?
Feb 02
Atrys Health, S.A. (BME:ATRY) Shares Could Be 33% Above Their Intrinsic Value Estimate
Dec 11CEO
Isabel Lozano Fernandez
no data
Tenure
Ms. Isabel Lozano Fernandez serves as Chief Executive Officer and Executive Director at Atrys Health, S.A. Ms. Lozano Fernández served as Chief Executive Officer and Managing Director of PharmaMar, SA. Ms....
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | no data | no data | 0.18% € 489.8k | |
| CEO & Executive Director | no data | no data | 0.44% € 1.2m | |
| Director | no data | no data | no data | |
| Director | no data | no data | no data | |
| Independent Director | no data | no data | 0.030% € 81.6k | |
| Independent Director | no data | no data | 0.030% € 81.6k | |
| Director | no data | no data | no data | |
| Proprietary Director | less than a year | no data | no data | |
| Proprietary Director | 3.1yrs | no data | no data | |
| Proprietary Director | 2yrs | no data | no data | |
| Independent Director | 1.6yrs | no data | no data |
1.8yrs
Average Tenure
Experienced Board: ATRY's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 14:03 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Atrys Health, S.A. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Luis Arredondo | Banco de Sabadell. S.A. |
| Victor Peiro Pérez | GVC Gaesco Valores |
| Joaquin Garcia-Quiros | JB Capital Markets |